Literature DB >> 9694343

Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period.

R Klein1, G Mölenkamp, N Sörensen, W Roggendorf.   

Abstract

Giant cell glioblastomas are defined as glioblastomas with a marked predominance of bizarre, multinucleated giant cells. They represent about 5% of all glioblastomas and can occur at any site of the central nervous system, but the temporal and frontal lobes are the sites of predilection. Overall, giant cell glioblastomas show a prolonged survival period compared with common glioblastoma multiforme, and survival periods of 7 and 9 years have been reported in adults. Here we report on a child aged 11 years at diagnosis, who has so far survived for 11 years since operation and adjunctive radio- and chemotherapy.

Entities:  

Mesh:

Year:  1998        PMID: 9694343     DOI: 10.1007/s003810050228

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  11 in total

1.  Magnetic resonance imaging and computed tomography findings in pediatric giant cell glioblastoma.

Authors:  L Zipp; K M Schwartz; E Hewer; Y Yu; C Stippich; J M Slopis
Journal:  Clin Neuroradiol       Date:  2012-12       Impact factor: 3.649

Review 2.  Pediatric giant cell glioblastoma: a case report and review of the literature.

Authors:  I De Prada; F Cordobés; D Azorín; T Contra; I Colmenero; I Glez-Mediero
Journal:  Childs Nerv Syst       Date:  2005-07-06       Impact factor: 1.475

3.  Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma.

Authors:  Prabal Deb; Mehar Chand Sharma; Bal Chander; Ashok Kumar Mahapatra; Chitra Sarkar
Journal:  Childs Nerv Syst       Date:  2005-08-16       Impact factor: 1.475

4.  Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas.

Authors:  Valerie C Bomben; Harald Sontheimer
Journal:  Glia       Date:  2010-08       Impact factor: 7.452

5.  MTH-68/H oncolytic viral treatment in human high-grade gliomas.

Authors:  L K Csatary; G Gosztonyi; J Szeberenyi; Z Fabian; V Liszka; B Bodey; C M Csatary
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

6.  Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome.

Authors:  Kuntal Kanti Das; Anant Mehrotra; Anup P Nair; Shaleen Kumar; Arun K Srivastava; Rabi N Sahu; Raj Kumar
Journal:  Childs Nerv Syst       Date:  2012-08-19       Impact factor: 1.475

7.  Pediatric giant cell glioblastoma: New insights into a rare tumor entity.

Authors:  Michael Karremann; Sandra Butenhoff; Ulrike Rausche; Torsten Pietsch; Johannes E A Wolff; Christof M Kramm
Journal:  Neuro Oncol       Date:  2008-12-02       Impact factor: 12.300

8.  Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.

Authors:  Kevin R Kozak; John S Moody
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

9.  Association between giant cell glioblastoma and glioblastoma multiforme in the United States: A retrospective cohort study.

Authors:  Amro K Bin Abdulrahman; Khalid A Bin Abdulrahman; Yousef R Bukhari; Abdulaziz M Faqihi; Juan Gabriel Ruiz
Journal:  Brain Behav       Date:  2019-08-29       Impact factor: 2.708

10.  Giant cell glioblastoma in the pediatric age group: Report of two cases.

Authors:  Sachin Anil Borkar; G Lakshmiprasad; Kiran Chikkanahalli Subbarao; Mehar Chand Sharma; Ashok K Mahapatra
Journal:  J Pediatr Neurosci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.